Loading...
•
Mar 31, 2025
TransMedics Q1 2025 Earnings Report
TransMedics reported financial results for the first quarter of 2025.
Key Takeaways
TransMedics delivered strong top and bottom-line financial results in Q1 2025, with total revenue increasing 48% year-over-year to $143.5 million and net income reaching $25.7 million. The company also raised its full-year 2025 revenue guidance.
Total revenue in Q1 2025 was $143.5 million, a 48% increase compared to Q1 2024.
Net income for Q1 2025 was $25.7 million, or $0.70 per fully diluted share.
Gross margin for Q1 2025 was 61%.
Cash was $310.1 million as of March 31, 2025.
Revenue by Segment
Forward Guidance
TransMedics raised its full-year 2025 revenue guidance.
Positive Outlook
- Raising full year 2025 revenue guidance to $565 million to $585 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...